Quality Payments: Support for meeting the asthma quality criterion

Quality Payments: Support for meeting the asthma quality criterion

November 19, 2018

Support is now available from PSNC and on PharmOutcomes to assist community pharmacy contractors with meeting the asthma quality criterion of the Quality Payments Scheme.

Contractors who plan to claim for this quality criterion are required, on the day of the review (15th February 2019), to show evidence of patients with asthma, for whom more than six short-acting bronchodilator inhalers were dispensed without any corticosteroid inhaler within a six month period, have since 29th June 2018 (i.e. the last review date) been referred to an appropriate healthcare professional for an asthma review. For this review point, contractors are also required to evidence that they have ensured that all children aged 5-15 years prescribed an inhaled corticosteroid for asthma have a spacer device, where appropriate, in line with the National Institute for Health and Care Excellence’s Technology Appraisal guidance 38 and have a personalised asthma action plan (PAAP). Referral to an appropriate healthcare professional should be made where this is not the case.

PSNC has published Briefing 060/18: Quality Payments – Referrals for asthma review, which provides background information on the asthma quality criterion as well as the following template resources:

  • Suggested processes for identifying suitable patients – For pharmacy teams to consider following or adapting to incorporate this quality criterion into their daily practice;
  • Briefing document for GP practices – Can be used by contractors to talk local GP practices through the referral process;
  • Letter to GP practices – Can be used in addition to the above GP Briefing document;
  • GP notification form – Can be used to refer a patient to their GP practice to advise that the patient may need their asthma management to be reviewed; and
  • Data collection form – Contractors may be required to provide evidence to NHS England to show that they have met the quality criterion; this form could be used to aid this process.

These resources are all available as standalone documents at: psnc.org.uk/asthmareferrals

PharmOutcomes support

Contractors can also access support on PharmOutcomes for this quality criterion. This support has been made available to all contractors, as PSNC has agreed to use their licence to provide access to the two asthma referral services on PharmOutcomes.

There are two services available; one for patients for whom more than six short-acting bronchodilator inhalers were dispensed without any corticosteroid inhaler within a six month period and one for children who have not been prescribed a spacer device and/or a PAAP. These can be accessing by logging into PharmOutcomes, selecting ‘Services’; and then ‘Quality Payment criterion – Asthma referrals’ and ‘Quality Payment criterion – Children’s asthma referrals’ are listed under the ‘Quality Payment Criteria’ heading.

The PharmOutcomes services allows contractors to record patient details who have consented to be referred to their GP practice. When this data is saved on PharmOutcomes, a referral will automatically be sent to the patient’s GP practice (if an NHSmail email address is held for that GP practice on PharmOutcomes).

If a contractor has not used PharmOutcomes before, log in details can be obtained by sending a message to the PharmOutcomes helpdesk. Contractors will need to provide details of the pharmacy, contact information and an email address to issue the login details to. 



Posted in: ,


More Latest News >

EPS Phase 4 piloting

NHS Digital continues to pilot EPS Phase 4. All pharmacy staff need to be aware that they could receive a...

PSNC Job Opportunity: Office Administrator

PSNC (the Pharmaceutical Services Negotiating Committee) represents England’s community (high-street) pharmacies, and is looking to recruit an Office Administrator to...